Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21) | PAR 17 004

Opportunity Information: Apply for PAR 17 004

Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21) is a National Institutes of Health funding opportunity (PAR 17-004) designed to spark new discoveries by encouraging researchers to re-use existing human datasets rather than collecting new data. The program sits within the NHLBI mission space, meaning it is aimed at questions that can advance knowledge in heart, lung, and blood diseases as well as sleep disorders. The central idea is to make strong, focused use of already-collected data to test novel hypotheses, explore new analytic angles, or develop and apply new tools, methods, models, or technologies that could meaningfully move biomedical or biobehavioral research forward.

The emphasis is explicitly on secondary analysis, meaning applicants are expected to work with datasets that already exist and were originally collected for a different primary purpose. Projects can be related to the original study goals, but they must be clearly distinct from the original specific aims. In other words, the application needs to show that it is not simply continuing the original project or repeating its planned analyses, but instead is taking the existing data in a new direction, such as asking a different scientific question, applying a new conceptual framework, using a different methodological approach, or examining outcomes, subgroups, exposures, or mechanisms that were not central to the original design. The opportunity does not support the collection of new data, so the proposed work should be feasible using available data resources (including appropriate permissions and access) and should be scoped to what can be accomplished through secondary analyses.

The award mechanism is an R21, which is typically used for exploratory or developmental research that can generate high-impact insights or set the stage for larger studies. The listing includes an award ceiling of $75,000, indicating the maximum amount available under this opportunity as presented in the source information. The funding instrument type is a grant, and the activity category is health, with CFDA numbers 93.233, 93.837, 93.838, 93.839, and 93.840 associated with NIH/NHLBI program areas.

Eligibility is broad and includes many types of organizations that might be positioned to conduct secondary analyses. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities. The announcement also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, non-domestic (non-U.S.) entities (foreign organizations), Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions. This wide eligibility reflects an intent to draw ideas from many sectors and communities, including institutions that serve historically underrepresented populations and organizations outside the United States when appropriate.

Administratively, the sponsoring agency is the National Institutes of Health. The source record shows a creation date of 2016-10-06 and an original closing date of 2019-10-30. As described, the purpose is not simply to encourage re-analysis for efficiency, but to motivate creative, high-yield use of existing data resources so that valuable datasets can produce additional knowledge beyond what was originally planned, especially when that new knowledge could have significant impact on NHLBI-relevant conditions and sleep health.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233, 93.837, 93.838, 93.839, 93.840.
• This funding opportunity was created on 2016-10-06.
• Applicants must submit their applications by 2019-10-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $75,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 17 004

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: